Churchill Capital Corp XI Units
NASDAQ:CCXIU · NASDAQ Global Market
-$0.04 today
Vol 0.00M · Avg 0.01M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
0.1%
avg 0.1%
ROIC
-0.0%
avg -0.0%
ROA
0.1%
avg 0.1%
Analysis
ROE is currently the strongest return metric at 0.1% versus its period average of 0.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Lee Jay Taragin | Chief Financial Officer | — | — | 60 | — | — |
Michael S. Klein | Founder, CEO, President & Chairman of the Board | — | — | 62 | $14.30M | 34.13% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$5.00M
Sells
0
$0.00
Net Sentiment
+$5.00M
Net buying
Most Active
Klein Michael Stuart
1 transactions
Analysis
Insiders reported 1 buys worth $5.00M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $5.00M. Klein Michael Stuart was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A — |
| Revenue | N/A | N/A | N/A | N/A — |
| Net Income | N/A | N/A | N/A | N/A — |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
No competitor data available.
Who manages CCXIU?
Churchill Capital Corp XI Units (CCXIU) lists 2 active executives. The top listed executive is Lee Jay Taragin, Chief Financial Officer.
Are CCXIU insiders buying or selling?
Recent insider activity shows net buying of $5.00M.
Explore More
Continue the stock analysis
Jump to another research area for this company.